This product is a blood lipid regulating drug of clofibric acid derivatives. Its mechanism of lowering blood lipids is not yet fully understood. It may reduce the cAMP content in liver microsomes, increase the activity of lipoprotein esterase, and decompose lipids in lipoproteins. Experimental and clinical studies have shown that this product reduces blood cholesterol and triglycerides and increases blood high-density lipoprotein. In addition, this product also has anti-platelet aggregation and anti-thrombotic effects and reduces blood uric acid.

1. Complexation: ① Heavy metal poisoning, it can complex copper, iron, mercury, lead, arsenic and other heavy metals to form soluble complexes and be excreted in urine; ② Wilson's disease, it combines with copper deposited in tissues to form soluble complexes and be excreted in urine; ③ Cystinuria and its stones, it reacts with cystine to reduce the concentration of cystine in urine and prevent the formation of cystine stones. 2. Anti-rheumatoid arthritis: It improves lymphocyte function, reduces the level of IgM rheumatoid factor and immune complexes in serum and joint cyst fluid, inhibits T cell activity, inhibits the cross-linking of newly synthesized procollagen, and is used to treat skin and soft tissue collagen diseases.

This product is a dopamine-like anti-Parkinson's disease drug. Levodopa is a precursor substance for synthesizing dopamine in the body. It has no pharmacological activity itself. It enters the central nervous system through the blood-brain barrier and is converted into dopamine by dopa decarboxylase to exert its pharmacological effects and improve the symptoms of Parkinson's disease. Since this product can increase neurotransmitters such as dopamine and norepinephrine in the brain, it can also improve the brain's tolerance to ammonia, and is used to treat hepatic coma, improve central nervous system function, make patients sober, and improve symptoms.

This product is a non-steroidal anti-inflammatory drug that can inhibit the synthesis of prostaglandins and exert anti-inflammatory and analgesic effects.

This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1~2mg/L, the histolytica amoeba can undergo morphological changes in 6~20 hours and all are killed within 24 hours. When the concentration is 0.2mg/L, the histolytica amoeba can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. It has a carcinogenic effect on some animals.